- Home
- LEXX vs GROV Comparison
LEXX vs GROV Comparison
Compare LEXX & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- GROV
- Stock Information
- Founded
- LEXX 2004
- GROV 2016
- Country
- LEXX Canada
- GROV United States
- Employees
- LEXX N/A
- GROV N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- GROV Package Goods/Cosmetics
- Sector
- LEXX Health Care
- GROV Consumer Discretionary
- Exchange
- LEXX Nasdaq
- GROV Nasdaq
- Market Cap
- LEXX 49.3M
- GROV 51.9M
- IPO Year
- LEXX N/A
- GROV N/A
- Fundamental
- Price
- LEXX $3.30
- GROV $1.31
- Analyst Decision
- LEXX Strong Buy
- GROV Buy
- Analyst Count
- LEXX 2
- GROV 1
- Target Price
- LEXX $11.00
- GROV $2.00
- AVG Volume (30 Days)
- LEXX 99.1K
- GROV 168.2K
- Earning Date
- LEXX 11-18-2024
- GROV 11-07-2024
- Dividend Yield
- LEXX N/A
- GROV N/A
- EPS Growth
- LEXX N/A
- GROV N/A
- EPS
- LEXX N/A
- GROV N/A
- Revenue
- LEXX $411,019.00
- GROV $227,251,000.00
- Revenue This Year
- LEXX $82.02
- GROV N/A
- Revenue Next Year
- LEXX $95.09
- GROV $5.97
- P/E Ratio
- LEXX N/A
- GROV N/A
- Revenue Growth
- LEXX 34.05
- GROV N/A
- 52 Week Low
- LEXX $0.85
- GROV $1.19
- 52 Week High
- LEXX $6.85
- GROV $2.62
- Technical
- Relative Strength Index (RSI)
- LEXX 53.27
- GROV 43.77
- Support Level
- LEXX $2.91
- GROV $1.24
- Resistance Level
- LEXX $3.39
- GROV $1.39
- Average True Range (ATR)
- LEXX 0.19
- GROV 0.08
- MACD
- LEXX 0.01
- GROV -0.01
- Stochastic Oscillator
- LEXX 80.00
- GROV 21.18
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.